rs138447102
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_021008.4(DEAF1):c.1186G>A(p.Gly396Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,614,020 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G396G) has been classified as Likely benign.
Frequency
Consequence
NM_021008.4 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, autosomal dominant 24Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- intellectual disability-epilepsy-extrapyramidal syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
- complex neurodevelopmental disorderInheritance: SD Classification: STRONG Submitted by: Illumina
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000861 AC: 131AN: 152172Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000732 AC: 184AN: 251454 AF XY: 0.000736 show subpopulations
GnomAD4 exome AF: 0.00120 AC: 1754AN: 1461848Hom.: 1 Cov.: 31 AF XY: 0.00120 AC XY: 875AN XY: 727224 show subpopulations
GnomAD4 genome AF: 0.000861 AC: 131AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.000794 AC XY: 59AN XY: 74320 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
- -
Intellectual disability-epilepsy-extrapyramidal syndrome Uncertain:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
DEAF1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at